Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Purpose The aim of this study was to examine patterns of radiotherapy (RT) in Korean patients with hepatocellular carcinoma (HCC) according to the evolving guideline for HCC established by the Korean Liver Cancer Study Group-National Cancer Center (KLCSG-NCC). Materials and Methods We reviewed 765 patients with HCC who were treated with RT between January 2011 and December 2012 in 12 institutions. Results The median follow-up period was 13.3 months (range, 0.2 to 51.7 months). Compared with previous data between 2004 and 2005, the use of RT as a first treatment has increased (9.0% vs. 40.8%). Increased application of intensity-modulated RT resulted in an increase in radiation dose (fractional dose, 1.8 Gy vs. 2.5 Gy; biologically effective dose, 53.1 Gy10 vs. 56.3 Gy10). Median overall survival was 16.2 months, which is longer than that reported in previous data (12 months). In subgroup analysis, treatments were significantly different according to stage (p < 0.001). Stereotactic body RT was used in patients with early HCC, and most patients with advanced stage were treated with three-dimensional conformal RT. Conclusion Based on the evolving KLCSG-NCC practice guideline for HCC, clinical practice patterns of RT have changed. Although RT is still used mainly in advanced HCC, the number of patients with good performance status who were treated with RT as a first treatment has increased. This change in practice patterns could result in improvement in overall survival.
Abstract
Purpose The aim of this study was to examine patterns of radiotherapy (RT) in Korean patients with hepatocellular carcinoma (HCC) according to the evolving guideline for HCC established by the Korean Liver Cancer Study Group-National Cancer Center (KLCSG-NCC). Materials and Methods We reviewed 765 patients with HCC who were treated with RT between January 2011 and December 2012 in 12 institutions. Results The median follow-up period was 13.3 months (range, 0.2 to 51.7 months). Compared with previous data between 2004 and 2005, the use of RT as a first treatment has increased (9.0% vs. 40.8%). Increased application of intensity-modulated RT resulted in an increase in radiation dose (fractional dose, 1.8 Gy vs. 2.5 Gy; biologically effective dose, 53.1 Gy10 vs. 56.3 Gy10). Median overall survival was 16.2 months, which is longer than that reported in previous data (12 months). In subgroup analysis, treatments were significantly different according to stage (p < 0.001). Stereotactic body RT was used in patients with early HCC, and most patients with advanced stage were treated with three-dimensional conformal RT. Conclusion Based on the evolving KLCSG-NCC practice guideline for HCC, clinical practice patterns of RT have changed. Although RT is still used mainly in advanced HCC, the number of patients with good performance status who were treated with RT as a first treatment has increased. This change in practice patterns could result in improvement in overall survival.
참고문헌 (20)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- Park JW, "Practice guideline for diagnosis and treatment of hepatocellular carcinoma", Korean J Hepatol, 10, pp.88~98 (2004)
- Seong J, "A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea", Liver Int, 29, pp.147~152 (2009)
- Korean Liver Cancer Study Group and National Cancer Center, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
- Forner A, "Current strategy for staging and treatment : the BCLC update and future prospects", Semin Liver Dis, 30, pp.61~74 (2010)
- Dawson LA, "Overview: where does radiation therapy fit in the spectrum of liver cancer local-regional therapies?", Semin Radiat Oncol, 21, pp.241~246 (2011)
- Lee IJ, "Radiotherapeutic strategies in the management of hepatocellular carcinoma", Oncology, 81(Suppl 1), pp.123~133 (2011)
- Cha J, "Application of radiotherapeutic strategies in the BCLC-defined stages of hepatocellular carcinoma", Liver Cancer, 1, pp.216~225 (2012)
- 한국 간 암 스터디그룹, "2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma", Gut and Liver, 9(3), pp.267~317 (2015), 거트앤리버 발행위원회
- Jang WI, "High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma", Radiat Oncol, 8, pp.250~ (2013)
- Huertas A, "Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma", Radiother Oncol, 115, pp.211~216 (2015)
- 배선현, "A Survey of Stereotactic Body Radiotherapy in Korea", Cancer Research and Treatment, 47(3), pp.379~386 (2015), 대한암학회[DOI]
- Choi C, "A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 90, pp.1051~1060 (2014)
- Cho JY, "The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma", Liver Int, 34, pp.795~801 (2014)
- Shim SJ, "Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma", Liver Int, 25, pp.1189~1196 (2005)
- Cha H, "Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma", J Radiat Res, 54, pp.1069~1077 (2013)
- Choi Y, "Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy", J Radiat Res, 55, pp.113~120 (2014)
- Kang MK, "High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma", Tumori, 97, pp.724~731 (2011)
- Yoon HI, "Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma", J Cancer Res Clin Oncol, 140, pp.1595~1605 (2014)
- Kim TH, "Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma", Strahlenther Onkol, 190, pp.882~890 (2014)